OnKure Therapeutics, Inc. (OKUR) has a consensus analyst rating of Buy, based on 2 analysts covering the stock. Of those, 2 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for OKUR is $35.00, representing a +660.0% upside from the current price of $4.605. Price targets range from a low of $35.00 to a high of $35.00.
